The active substance in Flegatussin Caps is bromhexine hydrochloride. This drug liquefies secretions from the respiratory tract and has an expectorant effect. Provides easier expectoration and effective bronchial cleansing.
Composition of Flegatussin Caps:
Active ingredient: Bromhexine hydrochloride (Bromhexini hydrochloridum). Each capsule contains 8 mg of bromhexine hydrochloride and excipients: capsule filling: macrogol 600, sodium hydroxide, ascorbic acid (E300), purified water; capsule shell: gelatin, liquid sorbitol, partially dehydrated (E420), patent blue V (E131), purified water.
Operation of Flegatussin Caps:
Flegatussin Caps is a drug indicated in acute and chronic respiratory diseases in the course of which it is difficult to expectorate a thick secretion. The drug contains bromhexine hydrochloride - an active substance that liquefies secretions from the respiratory tract and acts as an expectorant. Bromhexine hydrochloride capsules facilitate expectoration and help cleanse the bronchi.
The medicinal product Flegatussin Caps is indicated for use in the treatment of acute and chronic respiratory diseases that are associated with difficult expectoration of thick secretions.
Store the product out of reach of children at room temperature. It is recommended to protect against the effects of moisture and light. Use of the drug during pregnancy and breastfeeding: it is not recommended to use in the first trimester, and in the second and third only, if the benefit to the mother is greater than the risk to the child's health. Use during breastfeeding is not recommended. The drug may cause headache, dizziness and drowsiness, therefore caution should be exercised when driving or operating machinery. The drug contains sorbitol (E420) - people with diagnosed intolerance to certain sugars should consult a doctor. The drug contains patent blue (E131) - it may cause allergic reactions.
Do not use in case of hypersensitivity to any component of the drug. Do not use in children under 12 years of age.
Some people may experience side effects while taking the drug. Occurrence of severe side effects - hypersensitivity reactions, anaphylactic reactions (including anaphylactic shock), angioedema and pruritus, severe skin side effects (including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, generalized exanthema), spasm bronchitis, as well as the worsening of other side effects, it is necessary to discontinue use of the drug and consult a doctor as soon as possible. Uncommon side effects: nausea, abdominal pain (mainly upper abdominal pain), vomiting, diarrhea, fever. Rare side effects: hypersensitivity reactions, rash, urticaria. Side effects with an unknown frequency of occurrence:
Dosage of Flegatussin Caps capsules:
Use as directed on the leaflet or as directed by your doctor. The recommended dose for adults and adolescents over 12 years of age: one capsule three times a day. Taken orally after eating a meal, it should be taken at regular intervals. Do not take immediately before bedtime. If symptoms persist after 4-5 days, please consult your doctor. Usually treatment takes 7-10 days. During treatment, it is important to keep the body well-hydrated, it helps to thin the bronchial secretions and supports its expectoration. The secretion should be carefully coughed up.